Posts tagged with ‘astaxanthin’

  • BioCentric Energy Holdings announced multi-million dollar contract with Biocen Natural Products Development

    A multi-million dollar contract was signed between Daniel Kennedy, CEO and President of Biocen Natural Development Group (Pink Sheets:BNPD), a Nevada health drink company, and BEHL President, Monique Berry. The Nevada company, BNPD, is a public company consisting of a board of directors, a sales and marketing team and distribution outlets. BNPD, formerly Bionic Products, Inc., is currently undergoing a […]
    0
  • Cyanotech reports steady Q1 2011 for both its spirulina and astaxanthin products

    The Hawaiian healthy algae specialist has reported revenues of $3,856,000 for the quarter ended 30 June, compared to $4,021,000 for the same period last year. Gross profit margin remained at 43 per cent, and gross profit was $1657,000, down slightly from $1733,000. Its sales have been fairly evenly split between its two main products, spirulina (accounting for 51 percent of […]
    0
  • The Body of Research for Astaxanthin’s Health Benefits Continues to Grow

    Our colleagues at Cyanotech have provided the following research updates on astaxanthin: In a human study, Astaxanthin showed benefits for immune enhancement, oxidative stress & inflammation reduction and also decreased damage to DNA (Park, et al, 2010) In another promising human study, Astaxanthin reduced triglycerides and increased good cholesterol (HDL) in patients with mild hyperlipidemia (Yoshida, et al, 2010) A […]
    0
  • Aker BioMarine, Lipogen Come Together To Develop Phospholipids Formula

    Aker BioMarine, an integrated biotechnology company positioned to create value from krill harvesting and processing and Lipogen, a producer of the functional cognitive ingredient phosphatidylserine (PS), have joined forces to develop a phospholipids formula for cognitive health. Aker BioMarine and Lipogen said that the target formula is a matrix of Lipogen PS phosphatidylserine produced from Aker BioMarine’s pure Superba Krill […]
    0
  • Valensa International Recognized by Frost & Sullivan for Promoting Astaxanthin as an Eye Health Ingredient

    Based on its recent analysis of the eye health astaxanthin market, Frost & Sullivan recognizes Valensa International with the 2009 North American Frost & Sullivan Award for Customer Value Enhancement. Valensa has expanded the market for astaxanthin by positioning its Zanthin® Natural Astaxanthin product as an eye health ingredient and not just an anti-oxidant for general well-being. It holds the […]
    0
  • New Patent for Chemical-Free Krill Oil Extraction

    Tharos, a Chile-based consultancy firm,  has developed a new patent for krill oil extraction. The chemical-free process relates to a processing layout for obtaining krill oil with  DHA and EPA in the phospholipids fraction, with astaxanthin and neutral lipids, used for human health applications, and a byproduct of the process being a low fat content krill meal. More info
    0
  • Florida-based Valensa International has signed licensing agreements for its astaxanthin

    Valensa’s deal comes at the same time it has joined with krill omega-3 specialist, Neptune Technologies and Bioressources to develop astaxanthin-omega-3 combinations. Valensa says its patent-protected process (University of Illinois; US 5,527,533) can be used by New York-based FutureBiotics; North Dakota-based Swanson Health Products and Arizona-based Life Extension Vitamins in eye health supplements. The patent is relevant for light-induced retinal […]
    0
  • Cyanotech Announces 5 New Condition-Specific Formulas with Astaxanthin

    Cyanotech’s Medical Director Robert Corish, MD has now formulated five condition-specific recipes featuring BioAstin® Natural Astaxanthin as the “star” of each. There are many areas of medical research on Astaxanthin, which led Dr. Corish to combine BioAstin with the best, industry-leading nutrients for each condition in efficacious dosages. BioAstin’s benefits derive from its superior antioxidant activity and from its ability […]
    0
  • BioAstin Natural Astaxanthin Reduces CRP Levels by over 20% in Human Clinical Trial

    Recent company news reports that BioAstin® Natural Astaxanthin reduced C-reactive protein in a double blind, placebo controlled human clinical trial. The treatment group’s average CRP level went down an impressive 20.7% in just 8 weeks when taking BioAstin. Analysis of the results showed that they were statistically significant. C-reactive protein is a key measurement of systemic or “silent” inflammation. “Silent” […]
    0